138 related articles for article (PubMed ID: 16394122)
21. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
22. RNA Silencing in the struggle against disease.
Patzel V; Dietrich I; Kaufmann SH
Ann N Y Acad Sci; 2006 Oct; 1082():44-6. PubMed ID: 17145923
[TBL] [Abstract][Full Text] [Related]
23. Cyclohexanyl peptide nucleic acids (chPNAs) for preferential RNA binding: effective tuning of dihedral angle beta in PNAs for DNA/RNA discrimination.
Govindaraju T; Madhuri V; Kumar VA; Ganesh KN
J Org Chem; 2006 Jan; 71(1):14-21. PubMed ID: 16388612
[TBL] [Abstract][Full Text] [Related]
24. Identification and expression analysis of small RNAs during development.
Watanabe T; Imai H; Minami N
Methods Mol Biol; 2008; 442():173-85. PubMed ID: 18369786
[TBL] [Abstract][Full Text] [Related]
25. PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions.
Zhilina ZV; Ziemba AJ; Nielsen PE; Ebbinghaus SW
Bioconjug Chem; 2006; 17(1):214-22. PubMed ID: 16417271
[TBL] [Abstract][Full Text] [Related]
26. Molecular therapy in the microRNA era.
Wurdinger T; Costa FF
Pharmacogenomics J; 2007 Oct; 7(5):297-304. PubMed ID: 17189960
[TBL] [Abstract][Full Text] [Related]
27. Screening of siRNA target sequences by using fragmentized DNA.
Kasim V; Taira K; Miyagishi M
J Gene Med; 2006 Jun; 8(6):782-91. PubMed ID: 16532512
[TBL] [Abstract][Full Text] [Related]
28. Chimeric (aeg-pyrrolidine)PNAs: synthesis and stereo-discriminative duplex binding with DNA/RNA.
Lonkar PS; Ganesh KN; Kumar VA
Org Biomol Chem; 2004 Sep; 2(18):2604-11. PubMed ID: 15351824
[TBL] [Abstract][Full Text] [Related]
29. Target site effects in the RNA interference and microRNA pathways.
Obernosterer G; Tafer H; Martinez J
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1216-9. PubMed ID: 19021528
[TBL] [Abstract][Full Text] [Related]
30. RNA interference: the story of gene silencing in plants and humans.
Mahmood-ur-Rahman ; Ali I; Husnain T; Riazuddin S
Biotechnol Adv; 2008; 26(3):202-9. PubMed ID: 18221853
[TBL] [Abstract][Full Text] [Related]
31. Cellular delivery of peptide nucleic acids and inhibition of human telomerase.
Hamilton SE; Simmons CG; Kathiriya IS; Corey DR
Chem Biol; 1999 Jun; 6(6):343-51. PubMed ID: 10375543
[TBL] [Abstract][Full Text] [Related]
32. [Role of short RNAs in regulating the expression of genes and mobile elements in germ cells].
Klionov MS; Stoliarenko AD; Riazanskiĭ SS; Sokolova OA; Konstantinov IN; Gvozdev VA
Ontogenez; 2007; 38(3):213-27. PubMed ID: 17621977
[TBL] [Abstract][Full Text] [Related]
33. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
Salvi A; Arici B; Portolani N; Giulini SM; De Petro G; Barlati S
Int J Oncol; 2007 Aug; 31(2):451-60. PubMed ID: 17611703
[TBL] [Abstract][Full Text] [Related]
34. Antiviral applications of RNAi.
Morris KV; Rossi JJ
Curr Opin Mol Ther; 2006 Apr; 8(2):115-21. PubMed ID: 16610763
[TBL] [Abstract][Full Text] [Related]
35. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
[TBL] [Abstract][Full Text] [Related]
36. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing.
Janowski BA; Huffman KE; Schwartz JC; Ram R; Nordsell R; Shames DS; Minna JD; Corey DR
Nat Struct Mol Biol; 2006 Sep; 13(9):787-92. PubMed ID: 16936728
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of peptide ribonucleic acid (PRNA)-DNA chimera and interaction with DNA and RNA.
Wada T; Maeda Y; Sawa N; Sato H; Chon H; Kanaya S; Inoue Y
Nucleic Acids Symp Ser (Oxf); 2007; (51):21-2. PubMed ID: 18029566
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids.
Nekhotiaeva N; Awasthi SK; Nielsen PE; Good L
Mol Ther; 2004 Oct; 10(4):652-9. PubMed ID: 15451449
[TBL] [Abstract][Full Text] [Related]
39. Primer extension-based method for the generation of a siRNA/miRNA expression vector.
Gou D; Zhang H; Baviskar PS; Liu L
Physiol Genomics; 2007 Nov; 31(3):554-62. PubMed ID: 17804605
[TBL] [Abstract][Full Text] [Related]
40. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
